Longevity Wellness Pharmaceutical Market

Pharmaceutical therapies are set to lead therapy type at 38.0% share in 2026, followed by hospital pharmacies as likely to secure 37.0% share of distribution channel in 2026. Adoption rests on disease-specific endpoints and regulated clinical programs, with uncertain biomarkers and extended outcome timelines forming principal barriers.